Expression of nm23‐Hl and nm23‐H2 Proteins in Prostate Carcinoma

The nm23 gene products/nucleoside diphosphate (NDP) kinase expression in prostate carcinomas and benign hyperplasias was evaluated immunohistochemically. Monoclonal antibodies against nm23‐H1 and nm23‐H2 proteins were prepared using the corresponding proteins fused with glutathione S‐transferase as immunogens. Of the 80 cases of nonmetastatic prostate carcinoma examined, 74% (59/80) and 60% (48/80) were immunoreactive for nm23‐H1 or nm23‐H2 protein, respectively. Negative staining for nm23‐H1 occurred in 83% of metastatic lesions, while 34% were negative for nm23‐H2. All primary tumors corresponding to the metastases examined showed positive immunostaining for nm23‐H1, indicating an inverse relationship between expression of this protein and metastatic status. nm23‐H2 protein was detected in 83% of primary tumors and its expression appeared to he significantly correlated to the degree of histological differentiation. In contrast, all cases of benign prostatic hyperplasia showed elevated levels of both nm23‐H1 and nm23‐H2 expression. These data suggest that the nm23/NDP kinase may play a role in suppressing the expression of malignant potential in prostate carcinomas.

[1]  J. Strahler,et al.  High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification. , 1991, The Journal of clinical investigation.

[2]  L. Liotta,et al.  Reduced Nm23/Awd protein in tumour metastasis and aberrant Drosophila development , 1989, Nature.

[3]  B Angus,et al.  Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis. , 1991, Journal of the National Cancer Institute.

[4]  L. Liotta,et al.  A Drosophila gene that is homologous to a mammalian gene associated with tumor metastasis codes for a nucleoside diphosphate kinase , 1990, Cell.

[5]  T. Katada,et al.  Conversion of GDP into GTP by nucleoside diphosphate kinase on the GTP-binding proteins. , 1990, The Journal of biological chemistry.

[6]  W. Lee,et al.  Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Willson,et al.  Induction of nm23 gene expression in human colonic neoplasms and equal expression in colon tumors of high and low metastatic potential. , 1991, Journal of the National Cancer Institute.

[8]  S. Nagataki,et al.  Expression in human hepatocellular carcinoma of nucleoside diphosphate kinase, a homologue of the nm23 gene product. , 1992, Journal of the National Cancer Institute.

[9]  K. Watanabe,et al.  Isolation and characterization of a cDNA clone encoding rat nucleoside diphosphate kinase. , 1990, The Journal of biological chemistry.

[10]  A. Gilles,et al.  Nucleoside diphosphate kinase from human erythrocytes. Structural characterization of the two polypeptide chains responsible for heterogeneity of the hexameric enzyme. , 1991, The Journal of biological chemistry.

[11]  O. Myklebost,et al.  Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression. , 1992, Cancer research.

[12]  P. Steeg,et al.  H 2 Gene , nm 23 Identification of a Second Human Updated , 2006 .

[13]  J. Nickerson,et al.  The microtubule-associated nucleoside diphosphate kinase. , 1984, The Journal of biological chemistry.

[14]  H. Yokozaki,et al.  Reduced Expression of nm23 Is Associated with Metastasis of Human Gastric Carcinomas , 1993, Japanese journal of cancer research : Gann.

[15]  J E Talmadge,et al.  Evidence for a novel gene associated with low tumor metastatic potential. , 1988, Journal of the National Cancer Institute.

[16]  J. Ward,et al.  K‐ras activation and ras p21 expression in latent prostatic carcinoma in Japanese men , 1992, Cancer.

[17]  K. Fan,et al.  Heterogeneous subpopulations of human prostatic adenocarcinoma cells: potential usefulness of P21 protein as a predictor for bone metastasis. , 1988, The Journal of urology.

[18]  L. Liotta,et al.  Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm3-transfected melanoma cells , 1991, Cell.

[19]  K. Hirokawa,et al.  Positive relationship between expression of anti-metastatic factor (nm23 gene product or nucleoside diphosphate kinase) and good prognosis in human breast cancer. , 1991, Journal of the National Cancer Institute.

[20]  K. Ohtsuki,et al.  Direct activation of guanine nucleotide binding proteins through a high-energy phosphate-transfer by nucleoside diphosphate-kinase. , 1987, Biochemical and biophysical research communications.

[21]  L. Liotta,et al.  Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. , 1989, Cancer research.

[22]  H. Naiki,et al.  Presence of ras oncogene mutations and human papillomavirus DNA in human prostate carcinomas. , 1992, Cancer research.

[23]  P. Steeg,et al.  Tumor metastasis and nm23: current concepts. , 1991, Cancer cells.